Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Reinfection patients had more physical complications, while initial infection patients had more mental health issues.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Removing breast implants resolved the patient's symptoms.

COVID-19 can harm many body parts, not just the lungs.

The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Raising awareness about PCOS can improve women's quality of life.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.

The conference emphasized innovative solutions for global challenges, including disaster architecture, education, health, and economic impacts.

Continuous research and innovative strategies are essential for sustainable development.

Balancing hormones can help women feel youthful and healthy.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

The document provides 70 multiple choice questions to improve haematology skills.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

DHEA improved brain function and behavior in old monkeys and had additional health benefits.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.